National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

omeprazole
A benzimidazole with selective and irreversible proton pump inhibition activity. Omeprazole forms a stable disulfide bond with the sulfhydryl group of the hydrogen-potassium (H+ - K+) ATPase found on the secretory surface of parietal cells, thereby inhibiting the final transport of hydrogen ions (via exchange with potassium ions) into the gastric lumen and suppressing gastric acid secretion. This agent exhibits no anticholinergic activities and does not antagonize histamine H2 receptors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Prilosec
Foreign brand name:Losec
Abbreviation:OMEP
Code name:H168/68
Chemical structure name:5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole



Previous:oglufanide disodium, olanzapine, oligofructose-enriched inulin, oligonucleotide SPC2996, omacetaxine mepesuccinate
Next:Omnitarg, Oncaspar, Oncaspar-IV, OncoGel, OncoLAR

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov